<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-05-20T23:32:27Z</responseDate><request verb="GetRecord" identifier="oai:repisalud.isciii.es:20.500.12105/18351" metadataPrefix="mets">https://repisalud.isciii.es/rest/oai/request</request><GetRecord><record><header><identifier>oai:repisalud.isciii.es:20.500.12105/18351</identifier><datestamp>2024-11-28T15:36:47Z</datestamp><setSpec>com_20.500.12105_15322</setSpec><setSpec>com_20.500.12105_2051</setSpec><setSpec>col_20.500.12105_16927</setSpec></header><metadata><mets xmlns="http://www.loc.gov/METS/" xmlns:doc="http://www.lyncode.com/xoai" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" ID="&#xa;&#x9;&#x9;&#x9;&#x9;DSpace_ITEM_20.500.12105-18351" TYPE="DSpace ITEM" PROFILE="DSpace METS SIP Profile 1.0" xsi:schemaLocation="http://www.loc.gov/METS/ http://www.loc.gov/standards/mets/mets.xsd" OBJID="&#xa;&#x9;&#x9;&#x9;&#x9;hdl:20.500.12105/18351">
   <metsHdr CREATEDATE="2026-05-20T02:34:00Z">
      <agent ROLE="CUSTODIAN" TYPE="ORGANIZATION">
         <name>Repisalud</name>
      </agent>
   </metsHdr>
   <dmdSec ID="DMD_20.500.12105_18351">
      <mdWrap MDTYPE="MODS">
         <xmlData xmlns:mods="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
            <mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>López-Gambero, Antonio J.</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Rosell-Valle, Cristina</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Medina-Vera, Dina</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Navarro, Juan Antonio</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Vargas, Antonio</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Rivera, Patricia</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Sanjuan, Carlos</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Rodríguez de Fonseca, Fernando</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">author</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>Suárez, Juan</mods:namePart>
               </mods:name>
               <mods:name>
                  <mods:role>
                     <mods:roleTerm type="text">authoraffiliation</mods:roleTerm>
                  </mods:role>
                  <mods:namePart>[López-Gambero,AJ; Rosell-Valle,C; Medina-Vera,D; Navarro,JA; Vargas,A; Rivera,P; Rodríguez de Fonseca,F; Suárez,J] Instituto de investigación Biomédica de Málaga-IBIMA, Málaga, Spain. [López-Gambero,AJ; Medina-Vera,D; Navarro,JA; Vargas,A; Rivera,P; Rodríguez de Fonseca,F] UGC Salud Mental, Hospital Regional Universitario de Málaga, Málaga, Spain. [López-Gambero,AJ; Medina-Vera,D] Departamento de Biología Celular, Genética y Fisiología, Universidad de Málaga, Andalucia Tech, Málaga, Spain. [Medina-Vera,D; Navarro,JA; Suárez,J] Facultad de Medicina, Universidad de Málaga, Andalucia Tech, Málaga, Spain. [Medina-Vera,D] UGC Corazón, Hospital Universitario Virgen de la Victoria, Málaga, Spain. [Sanjuan,C] EURONUTRA S.L, Parque Tecnológico de Andalucía, Campanillas, Spain. [Suárez,J] Departamento de Anatomía Humana, Medicina Legal e Historia de la Ciencia, Universidad de Málaga, Málaga, Spain</mods:namePart>
               </mods:name>
               <mods:extension>
                  <mods:dateAccessioned encoding="iso8601">2024-02-19T15:28:24Z</mods:dateAccessioned>
               </mods:extension>
               <mods:extension>
                  <mods:dateAvailable encoding="iso8601">2024-02-19T15:28:24Z</mods:dateAvailable>
               </mods:extension>
               <mods:originInfo>
                  <mods:dateIssued encoding="iso8601">2021-05-20</mods:dateIssued>
               </mods:originInfo>
               <mods:identifier type="doi">10.3390/ijms22105365</mods:identifier>
               <mods:identifier type="e-issn">1422-0067</mods:identifier>
               <mods:identifier type="issn">1661-6596</mods:identifier>
               <mods:identifier type="journal">International Journal of Molecular Sciences</mods:identifier>
               <mods:identifier type="other">http://hdl.handle.net/10668/4486</mods:identifier>
               <mods:identifier type="pubmedID">34065168</mods:identifier>
               <mods:identifier type="uri">http://hdl.handle.net/20.500.12105/18351</mods:identifier>
               <mods:abstract>Increasing evidence links metabolic disorders with neurodegenerative processes including Alzheimer's disease (AD). Late AD is associated with amyloid (Aβ) plaque accumulation, neuroinflammation, and central insulin resistance. Here, a humanized AD model, the 5xFAD mouse model, was used to further explore food intake, energy expenditure, neuroinflammation, and neuroendocrine signaling in the hypothalamus. Experiments were performed on 6-month-old male and female full transgenic (Tg5xFAD/5xFAD), heterozygous (Tg5xFAD/-), and non-transgenic (Non-Tg) littermates. Although histological analysis showed absence of Aβ plaques in the hypothalamus of 5xFAD mice, this brain region displayed increased protein levels of GFAP and IBA1 in both Tg5xFAD/- and Tg5xFAD/5xFAD mice and increased expression of IL-1β in Tg5xFAD/5xFAD mice, suggesting neuroinflammation. This condition was accompanied by decreased body weight, food intake, and energy expenditure in both Tg5xFAD/- and Tg5xFAD/5xFAD mice. Negative energy balance was associated with altered circulating levels of insulin, GLP-1, GIP, ghrelin, and resistin; decreased insulin and leptin hypothalamic signaling; dysregulation in main metabolic sensors (phosphorylated IRS1, STAT5, AMPK, mTOR, ERK2); and neuropeptides controlling energy balance (NPY, AgRP, orexin, MCH). These results suggest that glial activation and metabolic dysfunctions in the hypothalamus of a mouse model of AD likely result in negative energy balance, which may contribute to AD pathogenesis development.</mods:abstract>
               <mods:language>
                  <mods:languageTerm authority="rfc3066">eng</mods:languageTerm>
               </mods:language>
               <mods:accessCondition type="useAndReproduction"/>
               <mods:subject>
                  <mods:topic>Alzheimer’s disease</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>5xFAD</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Insulin signaling</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Energy expenditure</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Hypothalamus</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Neuroinflammation</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Ghrelin</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Insulin resistance</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Leptin</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Orexin</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Resistin</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>STAT5 transcription factor</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Body weight</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Gastric inhibitory polypeptide</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Enfermedad de Alzheimer</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Proteínas sustrato del receptor de insulina</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Metabolismo energético</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Hipotálamo</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Enfermedades neuroinflamatorias</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Ghrelina</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Resistencia a la insulina</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Leptina</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Orexinas</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Resistina</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Factor de transcripción STAT5</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Peso corporal</mods:topic>
               </mods:subject>
               <mods:subject>
                  <mods:topic>Polipéptido inhibidor gástrico</mods:topic>
               </mods:subject>
               <mods:titleInfo>
                  <mods:title>A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer's Disease, the 5XFAD Mouse</mods:title>
               </mods:titleInfo>
               <mods:genre>research article</mods:genre>
            </mods:mods>
         </xmlData>
      </mdWrap>
   </dmdSec>
   <structMap LABEL="DSpace Object" TYPE="LOGICAL">
      <div TYPE="DSpace Object Contents" ADMID="DMD_20.500.12105_18351"/>
   </structMap>
</mets></metadata></record></GetRecord></OAI-PMH>